摘要
为研究生命树叙事疗法对减轻长期住院慢性稳定期精神分裂症患者病耻感的效用及影响因素,聚焦生命树叙事疗法对长期住院慢性稳定期精神分裂症患者的干预靶向。以生命树叙事疗法设置团体治疗方案,选取12名患者参与服务,在生命树叙事疗法治疗前后进行半结构式深度访谈,运用扎根理论对访谈资料进行分析。生命树叙事疗法的疗效共5个,分别为支持系统改善、病耻感降低、人际关系改善、自信心提高、参与团体治疗积极性提升。总结出生命树团体治疗影响因素核心类属4个,分别是团体过程、患者、带领者及其他影响因素。生命树团体治疗给患者带来的最大收获是支持系统的改善,能促进患者调整住院心态,转变不良情绪。患者在治疗过程中,对参与团体的期待发生了变化,将认真生活和活在当下变成了当前主要的目标,这是团体治疗的额外收获。
To study the effect and influencing factors of life tree narrative therapy on alleviating stigma in long-term hospitalized patients with chronic stable schizophrenia,and focus on its intervention targets for long-term hospitalization patients with chronic stable schizophrenia.The group therapy plan was set up with life tree narrative therapy,12 patients were selected to receive the therapy.Semi-structured in-depth interviews were conducted before and after the therapy of life tree narrative therapy,and grounded theory was used to analyze the interview data.There were 5 therapeutic effects of life tree narrative therapy,including improvement of support system,reduction of stigma,improvement of interpersonal relationship,self-confidence,and the enthusiasm for participating in group therapy.And four core categories of influencing factors of life tree group therapy were summarized,which were group process,patients,leaders and other influencing factors.The biggest gain of life tree group therapy for patients is the improvement of the support system,which can promote patients to adjust their inpatient mentality and change their negative emotions.During the process of therapy,patient’s expectations of participating in the group have changed,and serious living and living in the moment have become the main goal at present,which is an additional benefit of group therapy.
作者
黄碧华
陈燕华
HUANG Bihua;CHEN Yanhua(Social Work Department and External Cooperation Department,Shanghai Pudong New Area Mental Health Center,Shanghai 200124,China)
出处
《中国医学伦理学》
2023年第1期83-88,共6页
Chinese Medical Ethics
基金
浦东新区卫生系统医学人才培养计划“精神分裂症患者出院准备的多家庭小组介入研究”(PWRq2021-28)。
关键词
生命树叙事疗法
精神分裂症患者
病耻感
Life Tree Narrative Therapy
Patients with Schizophrenia
Stigma
